Evidence map›Paper›PMID 40994588›Full record

ArticleInternational journal of ophthalmology2025

Single subconjunctival injection formulation with a 5-fluorouracil-poly(lactic) acid controlled-release system for glaucoma filtration surgery.

Jing-Jing Zhang, Feng Gao, Kai-Xin Deng, Wen-Xue Guan, Yao-Yao Sun

Abstract read
In one paragraph

Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jing-Jing ZhangDepartment of Ophthalmology, Hospital of Tsinghua University, Tsinghua University, Beijing 100084, China.
Feng GaoDepartment of Ophthalmology, Peking University People's Hospital, Qingdao, Qingdao 266109, Shandong Province, China.
Kai-Xin DengDepartment of Ophthalmology, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100054, China.
Wen-Xue GuanDepartment of Ophthalmology, Peking University People's Hospital, Beijing 100044, China.
Yao-Yao SunDepartment of Ophthalmology, Peking University People's Hospital, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo develop a 5-fluorouracil (5-FU) mesoporous poly(lactic) acid (PLA) delivery system for glaucoma filtration surgery suitable for a single subconjunctival implantation.

methodsThe 5-FU was infiltration-loaded into mesoporous PLA.

resultsVarious drug formulations were tested, and two 5-FU-PLA tablets, namely 1.5P15 (5-FU 1.5 mg+PLA 15 000 Da) and 2.5P15 (5-FU 2.5 mg+PLA 15 000 Da), had the most suitable release profiles

conclusionThe tested 5-FU-PLA tablets provide a sustained release of 5-FU, which may be used for a single subconjunctival implantation to inhibit proliferation after filtration surgery.

Indexed as

5-fluorouracil mesoporous poly(lactic) acidfiltration surgeryglaucomasustained release system

Identifiers

PMID40994588
PMCPMC12453995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.